the reverse transcriptase inhibitor 2',3'-dideoxycytidine ( ddc ) is capable of mediating virologic and immunologic improvements in some patients with acquired immunodeficiency syndrome ( aids ) or aids-related complex .
C0012132
dideoxycytidine
C0001175
aids